Observational studies have found associations between GLP-1 agonist use for weight loss and increased risk of pancreatitis, but observational design cannot prove causality and absolute risk may be small at this point. Clinically, the rule is simple: severe persistent abdominal pain, especially if it radiates to the back with vomiting, is never something to wait out.

normativepending

Speaker

Dr. Amin Dadgar

Evidence Quote

“Observational studies have found associations between GLP-1 agonist use for weight loss and increased risk of pancreatitis. But observational design can't prove causality and absolute risk may be small at this point.”

Source

Ozempic & Mounjaro: Same Shot. Opposite Results.— Dr. Amin Hedayat, MD
Created: 8/12/2026, 6:40:36 PM

Your notes

Loading notes...